Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Neurocrine Biosciences, Inc. (NBIX)

« Back to company index

NBIX Chatter Timeline

Stock Ticker for NBIX

Most Active Tweeters for NBIX

UserTweets
@ChartMill 8
@AmericanBanking 5
@SwingTradeBot 2
@1MinuteStock 2
@StockTexts 2

Recent Tweets for NBIX

AmericanBanking @AmericanBanking
Haig P. Bozigian Sells 17,268 Shares of Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/QuMObZDUYm #stocks
June 17th 2019, 8:06pm
InsiderAlertsIA @InsiderAlertsIA
$NBIX: New Insider Filing on Chief Development Officer HAIG P. BOZIGIAN: https://t.co/dWJId57Ne4
June 17th 2019, 6:06pm
insiderbuyings @insiderbuyings
$NBIX new insider selling: 17268 shares. https://t.co/7DopyDlcdD
June 17th 2019, 6:06pm
StockTexts @StockTexts
$NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 4 https://t.co/1GN2v1AV9m
June 17th 2019, 5:06pm
ChartMill @ChartMill
$NBIX is growing strongly and shows a nice technical setup now! https://t.co/aCamqLEUON https://t.co/tcG9wmb9Jc
June 17th 2019, 4:06pm
JameyHarmon0 @JameyHarmon0
RT @OptionsHawk: $NBIX opens above consolidation, good amount of June call OI into expiration week - see if get some M&A in Neuro now as we…
June 17th 2019, 11:06am
OptionsHawk @OptionsHawk
$NBIX opens above consolidation, good amount of June call OI into expiration week - see if get some M&A in Neuro now as well
June 17th 2019, 9:06am
fda_tracker @fda_tracker
$NBIX Phase 2 trial w/est Jun completion date NCT03444038: https://t.co/gUpZFkH5TV Trial Tracker: https://t.co/aR7q5oJwjn
June 17th 2019, 9:06am
ProTradersNews @ProTradersNews
$ABBV $NBIX: Why AbbVie Is a Retiree’s Dream Stock: https://t.co/9rMSrFQqd0
June 17th 2019, 6:06am
WKRBNews @WKRBNews
Zacks: Brokerages Expect Neurocrine Biosciences, Inc. $NBIX Will Post Earnings of $0.27 Per Share https://t.co/ySQeH08BYS #markets
June 16th 2019, 1:06pm
MarketChmln @MarketChmln
$NBIX $NBIX upcoming event June 17: 2019 World Congress on Parkinson https://t.co/Cbcyx1f3dO
June 15th 2019, 10:06pm
dakotafinancial @dakotafinancial
Neurocrine Biosciences, Inc. $NBIX Expected to Announce Earnings of $0.27 Per Share https://t.co/tVmHWIhg0M
June 14th 2019, 11:06am
AmericanBanking @AmericanBanking
Neurocrine Biosciences, Inc. $NBIX Expected to Post Quarterly Sales of $165.23 Million https://t.co/S9ioAdCe9v #stocks
June 13th 2019, 5:06am
ChartMill @ChartMill
Our 'Technical Setups in Strongly Growing Stocks' lists $NBIX today! https://t.co/aCamqLEUON https://t.co/RiWgvelaHG
June 12th 2019, 5:06pm
ChartMill @ChartMill
$NBIX showing up in our top Strong Growth selection and may be ready for breakout. https://t.co/tQZ60Ree1L https://t.co/xfAL6evsou
June 12th 2019, 9:06am
newswelldone @newswelldone
$NBIX: Neurocrine Biosciences to Present Data on INGREZZA …: https://t.co/ANm3bgWFx2
June 11th 2019, 4:06pm
Allstocknews @Allstocknews
$NBIX Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congr From our Stock News Alerts App
June 11th 2019, 4:06pm
bthefirsttoknow @bthefirsttoknow
$NBIX Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congress on… https://t.co/DhdvzKXePy
June 11th 2019, 4:06pm
ChartMill @ChartMill
A very nice breakout setup pattern for $NBIX, will it break out? https://t.co/aCamqLEUON https://t.co/svDyqu0t3P
June 11th 2019, 3:06pm
newswithvalue @newswithvalue
$ATH $NBIX: Is Athene Holding Ltd. (ATH) A Good Stock To Buy?: https://t.co/QYHujCuUeY
June 11th 2019, 2:06pm
newswithvalue @newswithvalue
$NBIX $BWA: Hedge Funds Are Dumping Neurocrine Biosciences, Inc. (NBIX): https://t.co/KLb8FLhyOf
June 11th 2019, 2:06pm
SwingTradeBot @SwingTradeBot
50 DMA Support today: $ORCL $NBIX ... https://t.co/aW7zteKP9U
June 11th 2019, 12:06pm
ChartMill @ChartMill
$NBIX: The Revenue has grown by 122.83% in the past year. This is a very strong growth! https://t.co/d9JJnxhKLJ https://t.co/KhyhjkwOjG
June 11th 2019, 11:06am
AmericanBanking @AmericanBanking
Brokerages Expect Neurocrine Biosciences, Inc. $NBIX Will Post Earnings of $0.27 Per Share https://t.co/paDCitwzIA #stocks
June 11th 2019, 2:06am
ChartMill @ChartMill
$NBIX showing up in our top Strong Growth selection and may be ready for breakout. https://t.co/QJ4plZ3Wpw
June 10th 2019, 8:06am
ChartMill @ChartMill
A very nice breakout setup pattern for $NBIX, will it break out? https://t.co/aCamqLEUON https://t.co/TMPC4XjuX1
June 9th 2019, 11:06pm
MarketChmln @MarketChmln
$NBIX $NBIX upcoming event June 11: Goldman Sachs 40th Annual Global Healthcare Conference. Options expiring on Jun… https://t.co/uWSQRsXMXY
June 9th 2019, 8:06pm
TheMarketsDaily @TheMarketsDaily
Haig P. Bozigian Sells 3,435 Shares of Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/RKWqQxdsCn
June 8th 2019, 6:06am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $NBIX for you: 9.85% https://t.co/d1DQTIbmrF
June 8th 2019, 5:06am
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $NBIX https://t.co/73gJXzwcsf
June 8th 2019, 4:06am
ConsumerFeed @ConsumerFeed
Guggenheim Initiates Coverage on Neurocrine Biosciences $NBIX https://t.co/cDMNWuRMcM
June 8th 2019, 4:06am
WeekHerald @WeekHerald
Insider Selling: Neurocrine Biosciences, Inc. $NBIX Insider Sells 3,435 Shares of Stock https://t.co/bZSb378wK3
June 7th 2019, 7:06am
dailypoliticaln @dailypoliticaln
Neurocrine Biosciences, Inc. $NBIX Receives Consensus Recommendation of “Buy” from Analysts https://t.co/SVVdES1Gj9
June 6th 2019, 11:06pm
TickerReport @TickerReport
Haig P. Bozigian Sells 19,297 Shares of Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/hQsYOGldWl
June 6th 2019, 4:06am
AmericanBanking @AmericanBanking
Neurocrine Biosciences, Inc. $NBIX Insider Sells $293,726.85 in Stock https://t.co/ktsYkikEjS #stocks
June 5th 2019, 8:06pm
InsiderAlertsIA @InsiderAlertsIA
$NBIX: New Insider Filing on Chief Development Officer HAIG P. BOZIGIAN: https://t.co/BD29jMLxra
June 5th 2019, 6:06pm
StockTexts @StockTexts
$NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 4 https://t.co/jXiHPtWpcy
June 5th 2019, 6:06pm
SwingTradeBot @SwingTradeBot
Fell Below 50 DMA today: $NBIX $MERC ... https://t.co/j2lcQOTpfA
June 5th 2019, 11:06am
MC_OptionTrades @MC_OptionTrades
$NBIX $NBIX 21-Jun-19 Straddle Implies a ±7.4% move. Jun 6 Jefferies 2019 Global Healthcare Conference https://t.co/qDMpSzVjEf
June 5th 2019, 10:06am
firsttomarkets @firsttomarkets
Neurocrine Biosciences Inc Initiated Coverage by Guggenheim Securities (Ranked 5th) to Neutral $NBIX #NBIX https://t.co/mkv7qbruY5
June 5th 2019, 10:06am
BioStocks @BioStocks
$NBIX initiated at Neutral at Guggenheim, PT $88
June 5th 2019, 6:06am
1stOncology @1stOncology
#NeurocrineBiosciences to Present at Goldman Sachs 40th Annual Global #HealthcareConference $NBIX https://t.co/5TXrSYIDb1
June 5th 2019, 6:06am
stocknewstimes @stocknewstimes
Guggenheim Begins Coverage on Neurocrine Biosciences $NBIX https://t.co/C0sWoIIfSv
June 5th 2019, 5:06am
SleekMoneycom @SleekMoneycom
Guggenheim Begins Coverage on Neurocrine Biosciences $NBIX https://t.co/M56uR8lSTO #investing
June 5th 2019, 5:06am
dispatchtribune @dispatchtribune
Neurocrine Biosciences, Inc. $NBIX Insider Haig P. Bozigian Sells 19,297 Shares https://t.co/x46C5upH34
June 5th 2019, 4:06am
AmericanBanking @AmericanBanking
Neurocrine Biosciences $NBIX Research Coverage Started at Guggenheim https://t.co/jW52wdCH5X #stocks
June 4th 2019, 6:06pm
macondailynews @macondailynews
Neurocrine Biosciences $NBIX Now Covered by Analysts at Guggenheim https://t.co/blVlLC66dr
June 4th 2019, 6:06pm
PriceTargetsNet @PriceTargetsNet
$NBIX RATING INITIATED AT GUGGENHEIM SECURITIES. https://t.co/h8GNkXTD8F
June 4th 2019, 4:06pm
Allstocknews @Allstocknews
$NBIX Neurocrine Biosciences to Present at Goldman Sachs 40th Annual Global Healthcare Conference From our Stock News Alerts App
June 4th 2019, 4:06pm
ChartMill @ChartMill
$NBIX: a strong growth stock with a possibility for an entry now. https://t.co/4F9NyNvVyf https://t.co/j7KQHgcMu0
June 4th 2019, 10:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.